{"name":"Pakistan Blood and Marrow Transplant (PBMT) Group","slug":"pakistan-blood-and-marrow-transplant-pbmt-group","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ADDITION OF THALIDOMIDE AND HYDROXYUREA","genericName":"ADDITION OF THALIDOMIDE AND HYDROXYUREA","slug":"addition-of-thalidomide-and-hydroxyurea","indication":"Sickle cell disease (Phase 2)","status":"phase_2"}]}],"pipeline":[{"name":"ADDITION OF THALIDOMIDE AND HYDROXYUREA","genericName":"ADDITION OF THALIDOMIDE AND HYDROXYUREA","slug":"addition-of-thalidomide-and-hydroxyurea","phase":"phase_2","mechanism":"Thalidomide and hydroxyurea work synergistically to inhibit angiogenesis, promote apoptosis of abnormal cells, and enhance fetal hemoglobin production while reducing sickling and hemolysis.","indications":["Sickle cell disease (Phase 2)","Multiple myeloma or other hematologic malignancies (investigational)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9Db1ZHcncwZG4wNDdSYV80UEJaTEt3T2tGNVNXbF8tcExxWVdscFBaMFV0MjdpWmtEMjhqalhFbVRRM0luOVdzeG5UTFFHM0xZLWxOTnBVbU5ZbUpWZFZF?oc=5","date":"2025-11-05","type":"pipeline","source":"Nature","summary":"The 51st Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians – Poster Session (P001-P909) | Bone Marrow Transplantation - Nature","headline":"The 51st Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians – Poster Session (P001-","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}